Search for: "Pfizer Corporation"
Results 681 - 700
of 822
Sorted by Relevance
|
Sort by Date
24 Jan 2020, 10:24 am
Encompass Health – In June 2019, Encompass Health Corporation (formerly known as HealthSouth Corporation), the nation’s largest operator of inpatient rehabilitation facilities (IRFs), agreed to pay $48 million to resolve False Claims Act allegations in three separate whistleblower complaints that some of its IRFs provided inaccurate information to Medicare to maintain their status as an IRF and to earn a higher rate of reimbursement, and that some admissions to its IRFs… [read post]
1 May 2012, 2:16 pm
The Justice Department has filed cases against pharmaceutical manufacturers, like Pfizer, for dealings with state-run health care programs, and is reported to be pursuing an investigation into the dealings of American movie studios in China. [read post]
13 Jun 2012, 7:24 am
Eckard received an award of $96 million – an astounding number that was widely criticized by corporate interests at the time. [read post]
1 May 2012, 2:16 pm
The Justice Department has filed cases against pharmaceutical manufacturers, like Pfizer, for dealings with state-run health care programs, and is reported to be pursuing an investigation into the dealings of American movie studios in China. [read post]
16 Dec 2014, 4:28 am
A hostile tax inversion deal presents still more complicated communications issues for the acquirer, as illustrated by Pfizer’s recent run at AstraZeneca. [read post]
25 Jan 2007, 10:00 pm
Pfizer, 232 F.R.D. 360 (C.D. [read post]
2 Dec 2015, 2:13 pm
Chamber of Commerce, and United Technologies Corporation. [read post]
30 Oct 2010, 10:00 am
Intermarket Electroplasters (P) Ltd., Pfizer Products, Inc. v. [read post]
24 Apr 2012, 6:30 am
The Corporate IP Counsel Forum will address key issues and uncover latest developments related to IP in the form of case studies and panel discussions. [read post]
3 Jan 2013, 12:28 am
In addition, most of the antitrust litigation filed to date has named only corporate defendants. [read post]
30 Dec 2021, 9:03 pm
Many proposed actions reverse policies implemented by the Trump Administration, including plans to reverse Trump-era fuel economy standards back to maximum levels for passenger vehicles, propose disclosure rules for corporate board diversity and climate-related risks, and tighten regulations around oil and gas emissions and leasing. [read post]
9 Apr 2021, 8:03 am
Corporate leaders have some incentives to build more redundant and resilient supply chains going forward, such as by diversifying their supply base, holding more intermediate inventory, and adopting more flexible process innovations. [read post]
26 Jul 2019, 11:18 am
| TILTing Perspectives 2019 | Book review: Public rights – Copyright’s Public Domains | The Agreement on African Continental Free Trade Area (AfCFTA) - Protocol on IP | Lycra owner gets in a tight spot on costs: Unjust Part 36 offers, ex employees, breach of confidence & more | Book Review: Intellectual Property, Finance and Corporate Governance | IP law in Cambridge this summer [read post]
1 Jan 2019, 5:10 pm
In addition, the drug manufacturer Pfizer paid approximately $23.85 million to resolve claims that it used a foundation as a conduit to pay the co-pays of Medicare patients taking Pfizer drugs. [read post]
15 Mar 2008, 7:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WIPO Copyright Committee 16th session to discuss Broadcast Treaty, new proposal for exceptions and limitations agreement: (Public Knowledge), (Public Knowledge), (Intellectual Property Watch), (Public Knowledge), (Public Knowledge), (IPwar’s), (Intellectual Property Watch), (KEI), (Public Knowledge), (IP Justice), (IP Justice), (KEI), (KEI),… [read post]
12 Oct 2010, 6:30 am
Cuomo wiggles around on corporate taxes too. [read post]
30 Sep 2011, 3:14 am
Guest speakers include, Martha Ries, VP of IP Management, The Boeing Company and Barbara Dalton VP, Venture Capital, Pfizer. [read post]
9 Nov 2009, 4:19 am
You may also want to read Paul Hodgson's "Extraordinary merger bonuses at Pfizer" from The Corporate Library Blog. [read post]
20 Jul 2011, 4:04 am
(Spicy IP) US: Multicell Technologies receives stem cell patent (Patent Docs) US: FDA’s NDI guidance and the 18-year cycle of correcting regulatory overreach (FDA Law Blog) Products Adenoscan (Adenosine) – US: Astellas settles Adenoscan patent suit with Sagent and Strides Arcolab (Patent Docs) Angiomax (Bivalirudin) – US: The MDCO PTE decision: In play on Capitol Hill and in action at the PTO (FDA Law Blog) Cipralex (Escitalopram) – Austria: SPCs and Escitalopram in… [read post]
28 Oct 2011, 10:06 am
.; and Ellen Rosenthal, Pfizer Lisa Damon, Seyfarth Shaw LLP Seyfarth Lean Background: About 6 years ago, clients started asking for alternative fees. [read post]
